Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» severe oral mucositis
severe oral mucositis
Monopar Drops Lead Candidate after Disappointing Phase III Analysis
BioSpace
Wed, 03/29/23 - 09:51 am
Monopar Therapeutics
clinical trials
Validive
severe oral mucositis
chemotherapy
cancer
Monopar raises IPO Target to $46 Million
CP Wire
Wed, 09/11/19 - 09:57 am
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs
Monopar raises IPO Target to $46 Million
Wed, 09/11/19 - 09:53 am
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs
Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market
CP Wire
Mon, 09/24/18 - 03:34 pm
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
head and neck cancer
Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market
Mon, 09/24/18 - 10:13 am
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer
Wed, 05/9/18 - 09:43 am
Innovation Pharmaceuticals
Brilacidin
oral mucositis
severe oral mucositis
More Promising Data from Innovation Pharmaceutical's Phase 2 Brilacidin Oral Mucositis Study
CP Wire
Mon, 04/16/18 - 11:31 pm
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
Innovation Pharmaceuticals Reports on Successful Phase II Trial of Brilacidin-OM for Oral Mucositis
CP Wire
Mon, 04/9/18 - 03:39 pm
Innovation Pharmaceuticals
Brilacidin-OM
head and neck cancer
severe oral mucositis